Accelerated evolution and molecular surface of venom phospholipase A2 enzymes

Journal of Molecular Evolution

Volumn 48, Issue 2, 1999, Pages 125-132

  Kini, R Manjunatha ^a,b   Chan, Yiu Man ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Natural substitutions; Pharmacological effects; Protein evolution; Snake venom; Surface accessibility; Toxin

Indexed keywords

PHOSPHOLIPASE A2; SNAKE VENOM; TOXIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; DATA ANALYSIS; ENZYME ACTIVITY; EVOLUTION; GENE DUPLICATION; GENE MUTATION; NONHUMAN; PROBABILITY; PROTEIN IMMOBILIZATION; TARGET CELL;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; EVOLUTION, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; PHOSPHOLIPASES A; PROTEIN STRUCTURE, TERTIARY; SNAKE VENOMS;

SERPENTES;

EID: 0032953625     PISSN: 00222844     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00006450     Document Type: Article

References (50)

1. Abe T, Alema S, Miledi R (1977) Isolation and characterization of presynaptically acting neurotoxins from the venom of Bungarus snakes. Eur J Biochem 85:1-12
2. Agresti A (1996) An introduction to categorical data analysis. Wiley, New York
3. Bon C (1982) Synergism of the two subunits of crotoxin. Toxicon 20:105-109
4. Braganca BM, Sambray YM (1967) Multiple forms of cobra venom phospholipase A. Nature 216:1210-1211
5. 2 at 2.5 Å. Access to a shielded catalytic center. J Biol Chem 260:9742-9749
6. Brown AL (1987) Positively Darwinian molecules? Nature 326:12-13
7. Brown AJL, Richman DD (1997) HIV-1: Gambling on the evolution of drug resistance? Nature Med 3:268-271
8. Cairns J, Overbaugh J, Miller S (1987) The origin of mutants. Nature 335:142-145
9. 2. Toxicon 19:705-720
10. Connolly ML (1981) Solvent accessible surfaces of proteins and nucleic acids. Science 221:709-713
11. Creighton TE, Darby NJ (1989) Functional evolutionary divergence of proteolytic enzymes and their inhibitors. Trends Biochem Sci 14:319-324
12. Daltry JC, Wuster W, Thorpe RS (1996) Diet and snake evolution. Nature 379:537-540
13. 2 enzymes: Structure, function and mechanism. John Wiley, Chichester, UK, p 29
14. Deshimaru M, Ogawa T, Nakashima K, Nobuhisa I, Chijiwa T, Shimohigashi Y, Fukumaki Y, Niwa M, Yamashina I, Hattori S, Ohno M (1996) Accelerated evolution of crotalinae snake venom gland serine proteases. FEBS Lett 397:83-88
15. Dickerson R, Geis I (1969) Molecular carriers. The structure and action of proteins. WA Benjamin, New York, p 44
16. Hall BG (1990) Spontaneous point mutations that occur more often when advantageous than when neutral. Genetics 126:5-16
17. Harris JB (1985) Phospholipases in snake venoms and their effects on nerve and muscle. Pharmacol Ther 31:79-102
18. 2 based on structural determinants. J Biol Chem 252:4913-4921
19. Hill RE, Hastie ND (1987) Accelerated evolution in the reactive centre regions of serine protease inhibitors. Nature 326:96-99
20. Jayanthi GP, Gowda TV (1988) Geographic variation in India in the composition and lethal potency of Russell's viper (Vipera russelli) venom. Toxicon 26:257-264
21. Kimura M (1968) Evolutionary rate at the molecular level. Nature 217:624-626
22. King JL, Jukes TH (1969) Non-Darwinian evolution: Random fixation of selectively neutral mutations. Science 164:788-798
23. 2 enzymes: Structure, function and mechanism. John Wiley, Chichester, UK, p 1
24. 2. J Biol Chem 262:14402-14407
25. 2. Toxicon 27:613-635
26. 2. Biochemistry 33:13938-13945
27. Lambeau G, Barhainin H, Schweitz H, Qar J, Lazdunski M (1989) Identification and properties of very high affinity brain membrane-binding sites for a neurotoxic phospholipase from the taipan venom. J Biol Chem 264:11503-11510
28. 2 enzymes: Structure, function and mechanism. John Wiley, Chichester, UK, p 389
29. Laskowski M Jr, Kato I, Kohr WJ, Park SJ, Tashiro M, Whatley HE (1987) Positive Darwinian selection in evolution of protein inhibitors of serine proteinases. Proc Cold Spring Harbor Symp Quant Biol 52:545-553
30. LeClerc JE, Li B, Payne WL, Cebula TA (1996) High mutation frequencies among Escherichia coli and Salmonella pathogens. Science 274:1208-1211
31. Menez A (1993) Les structures des toxines des animaux venimaux. Pour la Sci 190:34-40
32. Menez A, Dauplais M (1997) As deadly as scorpion's sting. The diversity of toxins in scorpion venoms. Sci Spectra 8:44-50
33. Menez A, Bontems F, Roumestand C, Gilquin B, Toma F (1992) Structural basis for functional diversity of animal venoms. Proc Roy Soc Edinburgh 99B:83-103
34. 2 isoenzymes. Proc Natl Acad Sci USA 90:5964-5968
35. 2 isoenzyme genes. Proc Natl Acad Sci USA 92:5605-5609
36. Naylor GJP, Brown WM (1997) Structural biology and phylogenetic estimation. Nature 388:527-528
37. 2 isoenzyme-encoding genes. Gene 172:267-272
38. 2 isoenzymes. Proc Natl Acad Sci USA 89:8557-8561
39. Ohta T (1994) On hypervariability at the reactive center of proteolytic enzymes and their inhibitors. J Mol Evol 39:614-619
40. Ohta T, Kreitman M (1996) The neutralist-selectionist debate. BioEssays 18:673-683
41. Rosenberg P (1986) The relationship between enzymatic activity and pharmacological properties of phospholipases in natural poisons. In: Harris JB (ed) Natural toxins. Oxford University Press, Oxford, p 129
42. Rosenberg P (1990) Phospholipases In: Shier WT, Mebs D (ed) Handbook of toxinology. Marcel Dekker, New York, p 67
43. Salach JI, Turini P, Seng R, Hauber J, Singer TP (1971) Phospholipase A of snake venoms I. Isolation and molecular properties of isoenzymes from Naja naja and Vipera russelli venoms. J Biol Chem 246:331-339
44. 2 from Naja nigricollis venom inhibits the prothrombinase complex by a novel nonenzymatic mechanism. Biochemistry 29:7742-7746
45. 2 from the venom of Australian king brown snake (Pseudechis australis). Toxicon 28:319-327
46. 2 from the venom of Australian king brown snake Pseudechis australis. Toxicon 28:329-339
47. Tu AT (1977) Venoms: Chemistry and molecular biology. John Wiley, New York
48. 2 enzymes from habu (Trimeresurus flavoviridis) venom and their interaction with the alkaloid aristolochic acid. Toxicon 25:501-515
49. 2 in a complex with a transition-state analogue. Science 250:1560-1563
50. 2s on brain synaptic membranes. Biochemistry 30:11473-11477